On The Road: Institute Of Cannabis Science Goes To Washington
April 7, 2026
The two main subjects up for discussion in DC were the appropriation bill that redefined “hemp,” and the movement of marijuana to Schedule III
The two main subjects up for discussion in DC were the appropriation bill that redefined “hemp,” and the movement of marijuana to Schedule III
Featuring experts from Mass General Hospital and the Cannabis Chamber of Commerce, among other institutions
“Responsible cannabis consumers must no longer be threatened with federal prosecution and prison simply for exercising their 2nd Amendment rights.”
“This change has the potential to expand access to evidence-based therapies while maintaining strong safeguards”
Neither the president nor his spokespersons have provided any further updates regarding either their intentions or their timeline
Answers about Trump’s potential reclassification of marijuana including what could happen to current state programs
According to some lawmakers, the POTUS “has the opportunity to further reduce the harms of marijuana’s criminalization”
The Department of Health and Human Services recommended marijuana be moved to Schedule III last August and the Justice Department published a proposed rule to change cannabis’ classification in May. Here’s what’s next …
“The scientific evidence in favor of removing cannabis from Schedule I remains overwhelming.”
State cannabis advisors pass recommendations on rescheduling, island access, and vertical integration
